terbutaline has been researched along with Kidney Diseases in 2 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Administration of subcutaneous terbutaline obviates the need for intravenous access and should be considered as an alternative to nebulized or inhaled beta-agonists to treat acute hyperkalemia in patients with CKD." | 5.11 | Subcutaneous terbutaline use in CKD to reduce potassium concentrations. ( Cronin, D; Kraus, MA; Mueller, BA; Sowinski, KM, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avdeef, A | 1 |
| Tam, KY | 1 |
| Sowinski, KM | 1 |
| Cronin, D | 1 |
| Mueller, BA | 1 |
| Kraus, MA | 1 |
1 trial available for terbutaline and Kidney Diseases
| Article | Year |
|---|---|
Subcutaneous terbutaline use in CKD to reduce potassium concentrations.
Topics: Adrenergic beta-Agonists; Adult; Body Weight; Female; Heart Rate; Humans; Hyperkalemia; Injections, | 2005 |
1 other study available for terbutaline and Kidney Diseases
| Article | Year |
|---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological | 2010 |